Vaxinano
PrivateLast Round
Seed
Oct 29, 2024
Total Funding Raised
$7.09M
Company Overview
Vaxinano operates in Healthcare & Life Sciences and is based in Loos. Its latest recorded funding round was a Seed round in October 2024.
Vaxinano is a biotechnology company that develops prophylactic and therapeutic nasal vaccines intended to treat infectious diseases for human and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxinano Comparables
Compare Vaxinano with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lovaltech | 80% | |
| POP Biotechnologies, Inc. | 78% | |
| Xanadu Bio | 78% |
For institutional investors. Book with your work email.
Vaxinano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2024 | ||||
| Grant | Jun 1, 2020 | ||||
| Seed | Jun 22, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vaxinano Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
| WiSeed | Seed |
| Bpifrance | Seed |
| TCD Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$6.46M raised from Finorpa and Nord France Amorquage.
For institutional investors. Book with your work email.
Vaxinano Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vaxinano's valuation, stock price, and market status.
Is Vaxinano a public or private company?
Vaxinano is a private company.
What is the current stock price of Vaxinano?
Vaxinano is a private company, so its shares have no public market price. Caplight tracks Vaxinano's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vaxinano worth (valuation)?
Valuation information for Vaxinano is not publicly available.
Can I buy Vaxinano stock?
Vaxinano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vaxinano's last funding round?
Vaxinano's most recent funding round was Seed on October 29, 2024.
Who are the main investors in Vaxinano?
Key investors in Vaxinano include WiSeed, TCD Capital.
Will Vaxinano IPO soon?
No public IPO plans have been announced for Vaxinano.
How can I track Vaxinano secondary market activity?
Caplight tracks bids, offers, and trades in Vaxinano's shares on secondary markets.